Detall de la convocatòria

Característiques

Característica
Objectiu de la convocatòria
Funding for transnational projects on Antimicrobial Resistance
Característiques principals
This call aims to improve the treatment of bacterial and fungal infections (including co-infection) and/or the prevention of the emergence/spread of resistance in humans, animals or plants through the improvement of the efficacy, specificity, delivery, combinations and/or repurposing of drugs and plant protection agents.

Proposals should focus on licenced antimicrobial agents (antibiotics/antifungals) or agents under pre-clinical and/or early clinical development, and should address at least one of the following topics:
  • Improvement of drug/plant protection agent efficacy and/or specificity through chemical modifications (including hit to lead optimisation)
  • Drug/plant protection agent repurposing;
  • Optimisation of drug/plant protection agent combinations, alone or with adjunct therapies (including therapeutic vaccines);
  • Design and implementation of new strategies (including optimisation of drug doses) for improved application, efficacy and delivery of single or combinations of antimicrobials;
  • Design and implementation of innovative tools, including novel chemistry and/or new materials for improved application, efficacy and delivery of antimicrobials.

    Proposals can focus on one or more of the three “One-Health” settings, namely:
  • Human Health, and/or
  • Animal Health (including wildlife, livestock, fishes, and companion animals), and/or
  • Plants (including trees and crops)

    The following sub-topics are out of scope of the call:
  • Antiviral and antiparasitic agents
  • Discovery and/or screening of new compounds, new vaccines and/or new targets
  • Proposals solely aiming to develop new diagnostics or new companion diagnostics (companion diagnostics in evaluation of the antimicrobials can be examined but they should not be the main topic of the proposal.)
    • Lloc de presentació
    IMIM and PSMAR staff who need more information should contact::
    Competitive Funding. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.04.00.
    Carol Barnwell: cbarnwell@imim.es Ext.: 1670
    Marta López: mlopez4@imim.es Ext.: 1576
    Convocatòria (URL)
    https://www.jpiamr.eu/calls/therapeutics-call-2022/
    Submission Tool:
    https://ptoutline.eu/app/jpiamr2022_druid
    Informació addicional
    The call follows a two-stage procedure:
  • Deadline for pre-proposals March 8th, 2022
  • Deadline for full proposals: July 5th. 2022
    • Requisits
    The consortium must include a minimum of three (3) eligible partners asking for funding from three (3) different countries (at least two from EU Member States or AssociatedCountries).
    Maximum of six (6) project partners (including non-funded partners).The maximum number of partners can be increased to seven (7) if partners from underrepresented countries (including LMICs) are included in the consortium.
    Please consult the call text for detailed eligibility requirements.
    Dotació
    Up to €175,000/€250,000 for partners/coordinators
    Durada
    Up to 36 months.
    AVÍS IMPORTANT
    The call is made at European level but each partner of the consortium is funded by its national funding agency and must follow its national funding rules. Spanish participants are funded by ISCIII. There are eligibility requirements for the institutions and principal investigators funded by ISCIII. (please see annex B of the Call text).
    Due to the complexity of the call, if you are interested in submitting an application we strongly recommend that you contact the Servei de Recerca well in advance of the deadline.

    Arxius

    Arxiu
    Pre-proposal-form_JPIAMR-Therapeutics-call-2022.docx
    Call-text_JPIAMR-Therapeutics-call-2022_v.2022-01-13.pdf